BlockMedx (MDX)

BlockMedx (MDX)

Created using Figma
BlockMedx是一种符合HIPAA标准的端到端解决方案,用于将DEA控制的药物处方(例如阿片类镇痛药)从医生处方药物使用以太坊阻滞链发送到药房。
Sale
7月, 2018
9月, 2018
100% 完成
募集资金 - 无数据
past
令牌详细信息
接受的货币
ETH, BTC, WAN
公司详情
注册国家
United States
额外细节
KYC
分类
健康

关于 BlockMedx (MDX)

一种封闭式,加密安全的解决方案,用于使用以太坊区块链传输处方

BlockMedx恢复对开处方者的规定权限的完全控制。不再有处方伪造,重复或过度处方

每个处方必须与本机MDX令牌配对,以确保网络的安全性。患者还将使用MDX代币在药房和医生办公室支付共同支付费用。

特征

一种封闭式,加密安全的解决方案,用于使用以太坊区块链传输处方

BlockMedx恢复对开处方者的规定权限的完全控制。不再有处方伪造,重复或过度处方

每个处方必须与本机MDX令牌配对,以确保网络的安全性。患者还将使用MDX代币在药房和医生办公室支付共同支付费用。

技术信息

以太坊ERC20标准令牌。

%name%Roadmap

  • Q1 2017

  • The idea of BlockMedax is born;
    Start of conceptual work.
  • Q2 2017

  • Development of basic prototype;
    Outreach to relevant stakeholders and discussion of proposed solution.
  • Q3 2017

  • Completion of MVP;
    BlockMedx network goes live.
  • Q2 2018

  • Private sale;
    MassChallenge Accelerator start.
  • 阅读更多
  • Q3 2018

  • Public token sale;
    Intensive outreach to strategic partners.
  • Q4 2018

  • Pilot projects online: targeted areas will be Texas, Kentucky, Ohio and West Virginia;
    Version 2 Application Upgrades as Protocol Advances.
  • Q1 2019

  • Intensify implementations with healthcare systems;
    Rapid scalling into additional states with the highest opioid death rates;
    EMR and Telehealth platform API Access and Integration.
  • Q2 2019

  • Key partnership with addiction treatment organizations for patient education, communication, and early intervention;
    Expansion pf network into all prescription drugs with incorporation of communication, education, and early intervention incentive structures.
  • Q3 2019

  • Partnerships with payors and healthcare systems to allow discounted payments through patient portal and introduce new value based incentive structure that promotes early prevention rather than treatment.
  • Q4 2019

  • ML/AI implementations to automate detection of fraud and abuse in the healthcare system - important to prevent patients from being lost in the system after it is too late;
    Integration with Pharmaceutical supply chain to prevent counterfeit drugs from entering the market.

BlockMedx (MDX) 球队

验证 0%

注意。未经证实的成员实际上可能不是团队成员

Michael J Brunner
PharmD, Founder & CEO
未验证
Alexander Antoniou
MD MBA, Chief Medical Officer
未验证
Dave Hoover
Senior Blockchain Engineer
未验证

顾问

验证 0%

注意。未经证实的成员实际上可能不是团队成员

Jim Kyung-Soo Liew
Advisor
未验证

BlockMedx (MDX) 最新消息

  • 由于信息更新可能存在时间差异,因此应通过其官方网站或其他沟通渠道验证有关每个ICO项目的准确信息。
  • 这些信息不是投资ICO资金的建议或建议。请自行彻底调查相关信息并决定ICO的参与情况。
  • 如果您认为有任何问题需要纠正,或者您想提交自己的ICO项目,请给我们发送电子邮件。
请阅读免责声明和风险警告。 显示免责声明和风险警告。